(Q44701019)

5 December 2017

title

Gender differences in treatment response to sertraline versus imipramine in patients with nonmelancholic depressive disorders (English)

1 reference

5 December 2017

0 references

1 reference

Enrique Baca

1

1 reference

5 December 2017

Margarida Garcia-Garcia

series ordinal

2

1 reference

5 December 2017

Alberto Porras-Chavarino

series ordinal

3

1 reference

5 December 2017

publication date

1 January 2004

1 reference

Progress in Neuro-Psychopharmacology & Biological Psychiatry

5 December 2017

published in

1 reference

5 December 2017

volume

28

1 reference

5 December 2017

issue

1

1 reference

5 December 2017

page(s)

57-65

1 reference

Do the diagnostic criteria determine the sex ratio in depression?

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900177-5

7 January 2021

Sleep EEG, depression and gender

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900177-5

7 January 2021

Gender-based differences and menstrual cycle-related changes in specific diseases: implications for pharmacotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900177-5

7 January 2021

Gender differences in depression and antidepressant pharmacokinetics and adverse events

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900177-5

7 January 2021

Sex differences in recurrent depression: are there any that are significant?

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900177-5

7 January 2021

Clomipramine metabolism. Model-based analysis of variability factors from drug monitoring data

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900177-5

7 January 2021

Clinical implications of imipramine plasma levels for depressive illness

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900177-5

7 January 2021

Gender differences in psychiatric illness and treatments: a critical review

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900177-5

7 January 2021

Trazodone kinetics: effect of age, gender, and obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900177-5

7 January 2021

Role of estrogen in the aetiology and treatment of mood disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900177-5

7 January 2021

A rating scale for depression

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900177-5

7 January 2021

Development of a Rating Scale for Primary Depressive Illness

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900177-5

7 January 2021

Suicide in major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900177-5

7 January 2021

Antidepressant-induced sexual dysfunction during treatment with moclobemide, paroxetine, sertraline, and venlafaxine.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900177-5

7 January 2021

Sex and depression in the National Comorbidity Survey. I: Lifetime prevalence, chronicity and recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900177-5

7 January 2021

Gender differences in treatment response to sertraline versus imipramine in chronic depression

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900177-5

7 January 2021

Gender differences in the prevalence of depression: a survey in primary care

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900177-5

7 January 2021

Effect of aging and sex on the [3H]-paroxetine binding to human platelets.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900177-5

7 January 2021

Gender differences in the efficacy of fluoxetine and maprotiline in depressed patients: a double-blind trial of antidepressants with serotonergic or norepinephrinergic reuptake inhibition profile

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900177-5

7 January 2021

SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900177-5

7 January 2021

Plasma Levels of Imipramine and Desmethylimipramine during Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900177-5

7 January 2021

Why women are less likely than men to commit suicide.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900177-5

7 January 2021

Platelet serotonin functions in untreated major depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900177-5

7 January 2021

Gender differences in treatment response

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900177-5

7 January 2021

One-month prevalence of mental disorders in the United States. Based on five Epidemiologic Catchment Area sites

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900177-5

7 January 2021

Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 1: ethical and scientific issues

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900177-5

7 January 2021

Do depressed men and women respond similarly to cognitive behavior therapy?

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900177-5

7 January 2021

The Danish PET/depression project: PET findings in patients with major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900177-5

7 January 2021

Sex differences in rates of depression: cross-national perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900177-5

7 January 2021

10.1016/S0278-5846(03)00177-5

Identifiers

DOI

1 reference

5 December 2017

1 reference